Manulife (Manufacturers Life Insurance)’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$774K Sell
12,053
-12,820
-52% -$1.17M ﹤0.01% 1962
2025
Q4
$3.21M Buy
24,873
+2,903
+13% +$398K ﹤0.01% 1353
2025
Q3
$2.37M Buy
21,970
+9,093
+71% +$991K ﹤0.01% 1453
2025
Q2
$1.19M Buy
12,877
+1,267
+11% +$99.5K ﹤0.01% 1742
2025
Q1
$1.03M Buy
11,610
+679
+6% +$58.9K ﹤0.01% 1799
2024
Q4
$840K Sell
10,931
-47
-0.4% -$3.28K ﹤0.01% 1986
2024
Q3
$466K Sell
10,978
-124
-1% -$4.19K ﹤0.01% 2321
2024
Q2
$290K Buy
+11,102
New +$210K ﹤0.01% 2436
2023
Q2
Sell
-4,166
Closed -$50.2K 3062
2023
Q1
$50.2K Hold
4,166
﹤0.01% 2859
2022
Q4
$33.5K Sell
4,166
-2,069
-33% -$45.6K ﹤0.01% 2935
2022
Q3
$185K Sell
6,235
-38
-0.6% -$1.74K ﹤0.01% 2621
2022
Q2
$255K Buy
6,273
+1,983
+46% +$135K ﹤0.01% 2497
2022
Q1
$441K Buy
+4,290
New +$477K ﹤0.01% 2273

Other funds holding WGS

Manulife (Manufacturers Life Insurance)'s WGS Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its GeneDx Holdings (WGS) stake by 52% in Q1 2026, selling an estimated $1.17M and leaving 12,053 shares worth $774K. The position accounts for ﹤0.01% of the portfolio, ranked #1962.

Manulife (Manufacturers Life Insurance) first reported a position in WGS in Q1 2022 and has held it in 13 quarters since. The position peaked at $3.21M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 12,053 shares of GeneDx Holdings worth $774K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 12,820 GeneDx Holdings shares in Q1 2026, an estimated $1.17M.
  • GeneDx Holdings made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1962 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in GeneDx Holdings in Q1 2022 and has held it in 13 quarters since.
  • Manulife (Manufacturers Life Insurance)'s GeneDx Holdings position peaked at $3.21M in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.